The latest drug quality surveillance report of the Central Drugs Standard Control Organisation (CDSCO), found six medicine samples from Kashmir to be “Not of Standard Quality” (NSQ). While the identification of substandard drugs reflects that surveillance mechanisms are functioning, the findings also expose the persistent threat posed by poor-quality medicines to public health.

Medicines are not ordinary products. Patients trust them with their lives. When a medicine fails to meet quality standards, the consequences can be devastating. Equally worrying is the lack of transparency surrounding drug surveillance in Jammu........

© Greater Kashmir